Cloud Based Drug Discovery Platform Market Report 2026

Cloud Based Drug Discovery Platform Market Overview

• Cloud Based Drug Discovery Platform market size has reached to $3.61 billion in 2025 • Expected to grow to $6.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.4% • Growth Driver: Growing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Demand For Tailored Therapies • Market Trend: Technological Development In Molecular Modeling And Simulation Enhances Computational Efficiency And Predictive Accuracy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cloud Based Drug Discovery Platform Market?

Cloud based drug discovery platform is a digital solution that leverages cloud computing, advanced analytics, and artificial intelligence to accelerate the identification and optimization of potential drug candidates. It enables scalable data processing, secure collaboration, and high-performance computational workflows across the drug discovery lifecycle. The platform enhances research efficiency by integrating modeling, simulation, and data management capabilities within a centralized cloud environment. The main components of the cloud based drug discovery platform include software and services. Software refers to cloud-enabled platforms and tools used to support data management, modeling, simulation, and analytics in drug discovery. The drug discovery stages covered include target identification, lead discovery, preclinical development, and clinical development and the technologies utilized include machine learning, artificial intelligence, computational chemistry, and bioinformatics. The deployment models include Public Cloud, private cloud, and hybrid cloud, serving end users that include pharmaceutical companies, bioscience research organizations, academic institutions, and contract research organizations.

What Is The Cloud Based Drug Discovery Platform Market Growth Forecast?

The cloud based drug discovery platform market size is expected to see rapid growth in the next few years. It will grow to $6.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing use of artificial intelligence for drug design, growing implementation of hybrid and private cloud deployment models, rising integration of multi-omics data for drug discovery, expansion of contract research organizations and academic collaborations, increasing regulatory compliance and data security requirements. Major trends in the forecast period include increasing adoption of cloud-based drug discovery platforms, rising demand for virtual screening and molecular simulation tools, growth in ai-driven predictive modeling for drug candidate optimization, expansion of secure collaboration and data management services, increasing integration of bioinformatics and computational chemistry solutions.

What Is The Driver Of The Cloud Based Drug Discovery Platform Market?

The growing adoption of personalized medicine is expected to propel the growth of the cloud based drug discovery platform market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Cloud-based drug discovery platforms enhance personalized medicine adoption by providing scalable computing power and advanced analytics to analyze patient-specific genetic, molecular, and clinical data. They accelerate the identification of targeted therapies, improve drug efficacy, and enable tailored treatment plans, supporting more precise and effective healthcare solutions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the growing adoption of personalized medicine is driving the growth of the cloud based drug discovery platform industry.

Key Players In The Global Cloud Based Drug Discovery Platform Market

Major companies operating in the cloud based drug discovery platform market are Microsoft Corporation, Accenture plc, International Business Machines Corporation, Oracle Corporation, Tata Consultancy Services Limited, Dassault Systèmes SE, WuXi AppTec Co. Ltd., SAS Institute Inc., Schrödinger Inc., Valo Health Inc., Owkin Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Relay Therapeutics Inc., BenevolentAI Limited, Deep Genomics Inc., Collaborative Drug Discovery Inc., Iktos SAS, Nimbus Therapeutics LLC, and Optibrium Limited.

Global Cloud Based Drug Discovery Platform Market Trends and Insights

Major companies operating in the cloud based drug discovery platform market are focusing on developing advanced technological platforms, such as AI-driven drug discovery systems, to boost efficiency, enhance prediction accuracy, and reduce the time and cost of bringing new drugs to market. AI-driven drug discovery platforms refer to advanced computational systems that use artificial intelligence, including machine learning and structure prediction, to design and optimize drug candidates by analyzing biological data and molecular structures. For instance, in May 2025, Viva Biotech, a China-based biotechnology company, launched its AI-driven drug discovery (AIDD) platform, an advanced cloud-enabled solution for early-stage research. It is an advanced, comprehensive platform featuring three core modules, V-Scepter, V-Orb, and V-Mantle, that integrate structure prediction, molecular dynamics, and generative AI for de novo drug design. The platform includes capabilities like AI-generated antibody sequences (reducing initial discovery time from months to under a week), lab-in-the-loop iterative cycles, and proprietary Free Energy Perturbation calculations.

What Are Latest Mergers And Acquisitions In The Cloud Based Drug Discovery Platform Market?

In July 2023, BioNTech SE, a Germany-based biotechnology company, acquired InstaDeep Ltd. for an undisclosed amount. Through this acquisition, BioNTech strengthens its AI- and cloud-based drug discovery capabilities, enabling accelerated computational drug design, molecular modeling, and predictive analytics. InstaDeep Ltd. is a UK-based AI technology company specializing in cloud-based drug discovery platforms and AI-driven research and development solutions.

What Defines the Cloud Based Drug Discovery Platform Market?

The cloud based drug discovery platform market includes revenues earned by entities by providing services such as cloud-based computational modeling, virtual drug screening, bioinformatics data analysis, artificial intelligence-driven drug discovery, molecular simulation services, cloud-based collaboration and data management services, and regulatory and compliance support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The cloud based drug discovery platform market consists of sales of cloud-based drug discovery software platforms, artificial intelligence drug discovery tools, molecular modeling and simulation software, virtual screening software solutions, and cloud-based data management and integration tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cloud Based Drug Discovery Platform Market Report 2026?

The cloud based drug discovery platform market research report is one of a series of new reports from The Business Research Company that provides cloud based drug discovery platform market statistics, including cloud based drug discovery platform industry global market size, regional shares, competitors with a cloud based drug discovery platform market share, detailed cloud based drug discovery platform market segments, market trends and opportunities, and any further data you may need to thrive in the cloud based drug discovery platform industry. This cloud based drug discovery platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.